Analysts think IART stock price could increase by 25%
Jul 30, 2024, 6:25 AM
-19.20%
What does IART do
Integra LifeSciences Holdings Corp., based in Princeton, New Jersey, specializes in regenerative tissue technologies and neurological solutions, employing 3,722 people and operating through two segments: Codman Specialty Surgical and Tissue Technologies. The company offers a range of medical products, including neurosurgery instruments and complex wound surgery solutions, across multiple global manufacturing and research sites.
12 analysts think IART stock price will increase by 24.51%. The current median analyst target is $31.62 compared to a current stock price of $25.39. The lowest analysts target is $25.25 and the highest analyst target is $52.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
